Press Release

Preeclampsia Therapeutics Market: Analysis Based Regions, Types and Application

Preeclampsia Therapeutics Market | Potential Growth, Size, Share, Regional Analysis, Industry Outlook, Competitive Landscape, Trends, And Global Forecast To 2026

Increasing spread of preeclampsia worldwide will be the key driver of the global preeclampsia therapeutics market growth during the forecast period. Preeclampsia refers to a condition wherein a woman experiences high blood pressure during or after pregnancy. There may also occur low clotting factors, indicating problems of the liver or kidneys. The most potential causes identified by doctors for this condition are autoimmune disorders, genetic factors, and blood vessel issues. According to the Maternal Health Task Force under the Harvard Chan School, preeclampsia kills around 76,000 mothers and 500,000 babies globally every year. Moreover, in low and middle income countries, preeclampsia causes 16% of maternal deaths. This rising prevalence of the disorder will spur the demand for preeclampsia therapeutics and favor the growth of the global preeclampsia therapeutics market in the forecast period.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/preeclampsia-therapeutics-market-101516

Rising Incidence of Hypertension to Boost the Market

Close links have been established between hypertension (high blood pressure) and onset of preeclampsia. Women who have been suffering from chronic hypertension before pregnancy are more prone to developing preeclampsia during pregnancy. Hypertension has been on the rise worldwide. According to the World Health Organization (WHO), currently, around 1.13 billion are suffering from hypertension globally. The American Heart Association estimates that close to 50% of Americans are affected by hypertension. Thus, higher prevalence of hypertension is a major risk factor for preeclampsia, which will push up the demand for preeclampsia therapeutics till 2026. Furthermore, hypertension can also induce gestational diabetes in pregnant women, which, in turn, can cause the development of preeclampsia. This might lead to premature delivery of the baby and can cause stroke or seizure during labour and delivery. As diabetes becomes more prevalent, preeclampsia might become more common and lead to the expansion of the global preeclampsia therapeutics market size.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/preeclampsia-therapeutics-market-101516

Fortune Business Insights identifies some of the major competitors in the global preeclampsia therapeutics market:

  • Hoffmann-La Roche Ltd.
  • Sera Prognostics
  • Pluristem Therapeutics Inc.
  • DRG INSTRUMENTS GmbH
  • AMAG Pharmaceuticals
  • A1M Pharma AB
  • PerkinElmer Inc.
  • VG Lifesciences

More Trending Topics From Fortune Business [email protected]

How Worldwide Trends are Creating Waves in the Refractive Surgery Devices Market 2020

What is behind the Rise of the Oncology Molecular Diagnostics Market?

The Dravet Syndrome Market should see a stand-out year in 2020 | Fortune Business Insights™

Related Articles

Close